Biological Industries expands to the United States, providing innovative research technology to the U.S. life sciences market
CROMWELL, CT, USA & Kibbutz Beit Haemek, Israel, October 15, 2015 – Biological Industries (http://www.bioind.com/), a leading developer and manufacturer of cell culture media, molecular biology tools, human cytogenetics media, and custom media manufacturing services, announced today it will be expanding its operations to the United States. The company, which prides itself with over 30 years of cell culture media development expertise, state-of-the-art cGMP facilities, and key partnerships with some of the worlds’ leading scientists, will launch Biological Industries USA, Inc. (BI-USA) to market and distribute its products to the US market.
“The expansion is part of Biological Industries (BI) planned growth strategy and provides geographic support for scientists in the United States region,” says Alon Ariel, BI CEO. “Previously, BI has partnered with strategic distributors within the US in order to market our technology. With BI-USA, not only will our product portfolio be easily and directly available to US researchers, but they will now have direct access to our scientists and internal technical expertise as well.”
BI-USA will be focused on high-growth, establishing cell culture training programs, and expanding collaborations within the stem cell and conventional cell culture fields.
The organization is working towards launching the BI brand and developing a new, fully integrated global website, set to launch this fall. Customers can begin ordering products directly through BI-USA beginning October 1, 2015. Please contact Customer Service at 860-316-2702 or email email@example.com. BI-USA will be located on the East Coast in Cromwell, Connecticut. To learn more about the company’s expansion, please visit at www.bioind.com.
About Biological Industries
BIOLOGICAL INDUSTRIES (BI) develops, manufactures, and supplies life science products to universities, government research, healthcare institutions, and the biopharmaceutical industry. For over 30 years, BI has been working alongside some of the world’s leading academic researchers and institutes in the development of cell culture media, stem cell reagents, and molecular biology tools. BI also offers custom media development and manufacturing services through its ISO 13485:2003 certified cGMP facilities. BI currently supplies products to researchers and clinicians in over 40 countries. BI is leveraging their industry-leading experience in cell culture media and pluripotent stem cell technology to help facilitate breakthroughs in stem cell research worldwide.
BI is committed to a Culture of Excellence by providing the highest quality reagents and cost-effective, innovative products and services tailored to customers’ specific needs.